Provided by Tiger Trade Technology Pte. Ltd.

ALPHAMAB-B

8.305
-0.145-1.72%
Volume:1.10M
Turnover:8.92M
Market Cap:8.03B
PE:-69.21
High:8.415
Open:8.160
Low:7.825
Close:8.450
52wk High:15.750
52wk Low:6.230
Shares:967.00M
HK Float Shares:967.00M
Volume Ratio:1.17
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.120
ROE:-9.98%
ROA:-5.47%
PB:4.10
PE(LYR):-69.21
PS:13.25

Loading ...

Alphamab Oncology Maintains Steady Share Base in April 2026, Confirms Adequate Public Float

Bulletin Express
·
May 07

Alphamab Oncology Swings to Loss in 2025

MT Newswires Live
·
Apr 29

ALPHAMAB-B 2025年营收5.66亿元 研发投入攀升至5.72亿元致净亏1.14亿元

Bulletin Express
·
Apr 28

Alphamab Oncology publishes 2025 annual report

Reuters
·
Apr 28

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

ALPHAMAB-B Grants 250,000 Award Shares to Two Employees

Stock News
·
Apr 23

Alphamab Oncology grants 250,000 restricted share awards to employees under incentive scheme

Reuters
·
Apr 23

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress
·
Apr 23

ALPHAMAB-B Secures Three-Year HKEX Waiver to Appoint Jiang Rui as Joint Company Secretary

Bulletin Express
·
Apr 22

ALPHAMAB-B's KN026 Breast Cancer Trial Results Selected for Oral Presentation at 2026 ASCO Annual Meeting

Stock News
·
Apr 22

Alphamab Oncology: KN026 Phase III Neoadjuvant Breast-Cancer Results Chosen for 2026 ASCO Late-Breaking Oral Session

Bulletin Express
·
Apr 22

Alphamab Oncology says KN026 Phase III neoadjuvant breast cancer results selected for ASCO LBA oral session

Reuters
·
Apr 22

ALPHAMAB-B Shares Surge Over 12% in Morning Session as KN026 Commercialization Nears

Stock News
·
Apr 13

ALPHAMAB-B Announces Appointment of Jiang Rui as Joint Company Secretary

Stock News
·
Apr 08

Alphamab Oncology names Jiang Rui joint company secretary, authorized representative

Reuters
·
Apr 08

Alphamab Oncology Keeps Share Base Steady at 974.29 Million Shares in March; Confirms 25%+ Public Float

Bulletin Express
·
Apr 08

Assessing Alphamab Oncology (SEHK:9966) Valuation After A Mixed Period Of Share Price Returns

Simply Wall St.
·
Apr 07